According to Americantelemed.org, more than half of all U.S. hospitals currently have a telemedicine program.
The global telemedicine technologies market was valued at $17.8 billion in 2014 and is predicted to grow at a compound annual growth rate of 18.4% from 2014 to 2020, according to ResearchandMarkets.com.
Mike Noshay, co-founder and chief strategy officer for Verinovum, a health care data analytics company headquartered in Tulsa, said the rise of telemedicine has created a unique opportunity and an equally great challenge for the market.
“Consumers reap the benefit of empowered engagement of the health care ecosystem but their primary care providers often lack visibility into prescribed treatment plans outside of their four walls,” said Noshay. “We at Verinovum believe that the growth of telemedicine providers will heighten the need for data cleansing, curation and delivery to other portions of the health care ecosystem.”
The current health crisis will likely make tele-delivered medicine a new norm. Consumers will expect the ease of use and engagement levels experienced during virtual visits, he said.